紧抓政策和市场机遇 国际医学拟募资加码智慧康养和精准放疗

Group 1 - International Medical aims to create a dual-driven development model of "comprehensive medical care + specialized departments" and has announced a plan to raise up to 1.008 billion yuan through a targeted stock issuance [1] - The raised funds will primarily be invested in smart health care projects, the second phase of the proton therapy center, and to supplement working capital [1] Group 2 - The aging population in China is increasing, with approximately 220 million people aged 65 and above expected by the end of 2024, representing 15.6% of the total population [2] - China's total healthcare expenditure has grown from 3.54 trillion yuan in 2014 to 9.06 trillion yuan in 2023, with a compound annual growth rate of 11.01% [2] - The demand for healthcare services is expected to rise due to the increasing elderly population and enhanced health awareness among residents [2] Group 3 - The proportion of nursing beds in registered elderly care institutions in China was 65.7% by the end of 2024, indicating significant growth potential in the elderly care industry [3] - Policies have been introduced to promote the integration of medical and elderly care services, aiming to improve the care system for elderly individuals with disabilities or dementia [3] Group 4 - Proton therapy is highlighted as a cutting-edge cancer treatment method with high cure rates and low side effects, addressing the limitations of traditional radiation therapy [4] - There is a significant market demand for proton therapy in China, with only seven operational proton therapy centers as of 2024, despite approximately 4.8247 million new cancer cases reported in 2022 [4] Group 5 - The health policy framework aims to enhance cancer prevention and treatment systems by 2030, with a planned increase in the number of radiation therapy devices [5] - The proton therapy center's second phase project aligns with national industrial policy and aims to enhance the company's high-end diagnostic capabilities [6] Group 6 - The implementation of the fundraising projects will enable the company to extend its business from traditional diagnostics to high-end radiation therapy, creating a synergistic business model of "comprehensive diagnosis + precise radiation therapy" [6] - The projects will leverage existing medical resources to strengthen the company's core competitiveness in cancer treatment [6]